Preparation for ICH Meetings in Brussels, Belgium, Including Progress on Implementing of the Common Technical Document; Public Meeting; Cancellation
---
identifier: "/us/fr/01-24528"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Preparation for ICH Meetings in Brussels, Belgium, Including Progress on Implementing of the Common Technical Document; Public Meeting; Cancellation"
title_number: 0
title_name: "Federal Register"
section_number: "01-24528"
section_name: "Preparation for ICH Meetings in Brussels, Belgium, Including Progress on Implementing of the Common Technical Document; Public Meeting; Cancellation"
positive_law: false
currency: "2001-10-01"
last_updated: "2001-10-01"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "01-24528"
document_type: "notice"
publication_date: "2001-10-01"
agencies:
- "Health and Human Services Department"
- "Food and Drug Administration"
fr_citation: "66 FR 49964"
fr_volume: 66
docket_ids:
- "Docket No. 01N-0370"
fr_action: "Notice."
---
# Preparation for ICH Meetings in Brussels, Belgium, Including Progress on Implementing of the Common Technical Document; Public Meeting; Cancellation
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Notice.
**SUMMARY:**
The Food and Drug Administration (FDA) is canceling the public meeting for the ICH meetings in Brussels, Belgium scheduled for October 5, 2001. The public meeting was announced in the *Federal Register* of September 7, 2001 (66 FR 46801). It will be rescheduled at a later date.
**FOR FURTHER INFORMATION CONTACT:**
Kimberly Topper, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7001.
Dated: September 25, 2001.
Margaret M. Dotzel,
Associate Commissioner for Policy.